Ashley Magargee
Switzerlandbusiness executiveFemale6.0Global Dominance: 0.00%Ashley Magargee is the CEO of Genentech, part of the Roche Group, which is a leading biotechnology company. She was featured in the news for announcing a significant $50 billion commitment to biotech manufacturing and research during a White House event.
Country presence
Recent news mentions
Ashley Magargee is the CEO of Genentech, a subsidiary of Roche, involved in the drug pricing agreements.
Die USA untersuchen die Medikamentenpreise in DeutschlandSwitzerland· 2026-06-20
Ashley Magargee is the CEO of Genentech, a Roche subsidiary, who was present at a White House announcement regarding drug pricing.
Neues Werk von BMS in Boudry erhält Konkurrenz aus USASwitzerland· 2026-05-28
Ashley Magargee is the CEO of Genentech, a subsidiary of Roche, involved in the drug pricing agreement with the US government.
«Es steht viel auf dem Spiel»Switzerland· 2026-03-07
Ashley Magargee, CEO of Genentech, was present at the announcement of a deal with the U.S. government regarding drug prices.
Was bringt Donald Trumps Medikamenten-Website?Switzerland· 2026-02-07
Ashley Magargee is the CEO of Genentech, the American subsidiary of Roche, and was present during the announcement of a deal with the U.S. government.
Roche macht deutlich mehr GewinnSwitzerland· 2026-01-29
Ashley Magargee, CEO of the American Roche subsidiary Genentech, was present at the announcement in the White House.
Chinesische Firmen holen in Entwicklung aufSwitzerland· 2026-01-14Ashley Magargee, CEO of Genentech, represented Roche at the announcement of drug pricing agreements.
«Standortwettbewerb hat neue Dimension erreicht»Switzerland· 2025-12-24
Ashley Magargee is the CEO of Genentech, a subsidiary of Roche, who was present during the announcement at the White House.
Willkommener Weckruf für die SchweizSwitzerland· 2025-12-22Ashley Magargee is the head of Genentech, the American subsidiary of Roche.
Roche-Präsident Schwan zwischen Trump und Standort SchweizSwitzerland· 2025-08-13
Genentech, led by Ashley Magargee, announced a massive $50 billion commitment to biotech manufacturing and research.
Trump touts trillion-dollar surge in U.S. investment — here’s who’s cashing in
United States· 2025-05-01
